INFUSYSTEM HOLDINGS, INC Total Liabilities
INFUSYSTEM HOLDINGS, INC (INFU) had Total Liabilities of $38.55 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-04
- 2026-06-30: Liabilities $38.55M.
- 2026-03-31: Liabilities $39.91M.
- 2025-12-31: Liabilities $43.23M.
- 2025-09-30: Liabilities $43.41M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $38.55M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $39.91M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $43.23M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $43.41M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $46.31M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $49.13M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $46.09M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $49.79M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $55.04M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $52.57M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $50.61M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $50.60M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $52.79M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $54.00M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $51.38M 10-K · filed 2024-04-10 | |
| 2022-09-30 | $51.17M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $52.32M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $52.18M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $49.31M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $48.33M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $51.30M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $47.64M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $56.24M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $50.92M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $57.77M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $60.66M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $56.89M 10-K · filed 2021-03-22 | |
| 2019-09-30 | $56.18M 10-Q · filed 2019-11-14 | |
| 2018-12-31 | $43.63M 10-K · filed 2020-03-30 | |
| 2017-12-31 | $37.93M 10-K · filed 2018-03-19 | |
| 2017-09-30 | $36.59M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $40.01M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $42.26M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $45.66M 10-K · filed 2018-03-19 | |
| 2016-09-30 | $46.11M 10-Q · filed 2016-12-12 | |
| 2016-06-30 | $47.33M 10-Q/A · filed 2016-12-12 | |
| 2016-03-31 | $48.09M 10-Q/A · filed 2016-12-12 | |
| 2015-12-31 | $45.04M 10-K · filed 2017-03-22 | $45.17M 10-K · filed 2016-03-09 |
| 2015-09-30 | $44.78M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $44.27M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $41.14M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $33.76M 10-K/A · filed 2016-12-12 | |
| 2014-09-30 | $35.74M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $33.37M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $34.80M 10-Q · filed 2014-05-05 | |
| 2013-12-31 | $34.65M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $34.77M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $34.94M 10-Q · filed 2013-08-13 | |
| 2013-03-31 | $35.70M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $37.51M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $34.69M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $35.52M 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $36.09M 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $36.10M 10-K · filed 2013-03-28 | |
| 2011-09-30 | $38.77M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $36.41M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $45.22M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |